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SUMMARY OF THE 2015 CDC SEXUALLY TRANSMITTED DISEASE (STD) TREATMENT GUIDELINES 
MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (MDPH) – DIVISION OF STD PREVENTION (DSTDP) 
 
These guidelines for treatment of STDs reflect recommendations of the MDPH DSTDP and of the CDC STD Treatment 
Guidelines. These guidelines focus on STDs encountered in outpatient settings and are not an exhaustive list of effective 
treatments. Please refer to the complete CDC document for more information or call the DSTDP. Clinical and epidemiological 
services are available through the DSTDP including staff to assist healthcare providers with confidential notification of sexual 
partners of patients with STDs and/or HIV infection. Please call the DSTDP for assistance at (617) 983-6940. 
 
DISEASE RECOMMENDED TREATMENT 
ALTERNATIVES 
(use only if recommended regimens are 
contraindicated) 
SYPHILIS 
ADULTS 
PRIMARY, SECONDARY OR EARLY LATENT (<1 YEAR) • Benzathine penicillin G 2.4 million units IM once 
(For penicillin-allergic non-pregnant patients only) 
• Doxycycline 100 mg orally 2 times a day for 14 days OR 
• Tetracycline 500 mg orally 4 times a day for 14 days 
ADULTS 
LATE LATENT (>1 YEAR) OR LATENT OF UNKNOWN 
DURATION 
• Benzathine penicillin G 2.4 million units IM for 3 doses at 
1 week intervals (total 7.2 million units) 
(For penicillin-allergic non-pregnant patients only) 
• Doxycycline 100 mg orally 2 times a day for 28 days OR 
• Tetracycline 500 mg orally 4 times a day for 28 days 
NEUROSYPHILIS 
including 
 OCULAR SYPHILIS 
• Aqueous crystalline penicillin G 18-24 million units per 
day, administered as 3-4 million units IV every 4 hours or 
continuous infusion, for 10-14 days1 
• Procaine penicillin G 2.4 million units IM once daily PLUS 
probenecid 500 mg orally 4 times a day, both for 10-14 
days 
CHILDREN 
PRIMARY, SECONDARY OR EARLY LATENT (<1 YEAR) 
• Benzathine penicillin G 50,000 units/kg IM once, up to 
adult dose of 2.4 million units 
No specific alternative regimens exist. CHILDREN 
LATE LATENT (>1 YEAR) OR LATENT OF UNKNOWN 
DURATION 
• Benzathine penicillin G 50,000 units/kg IM (up to adult 
dose of 2.4 million units) for 3 doses at 1 week intervals 
(up to total adult dose of 7.2 million units) 
CONGENITAL SYPHILIS See complete CDC guidelines. 
HIV INFECTION Same stage-specific recommendations as for HIV-negative persons. 
PREGNANCY Penicillin is the only recommended treatment for syphilis during pregnancy. Women who are allergic should be desensitized and treated with penicillin. Treatment is the same as in non-pregnant patients for each stage of syphilis.2 
GONOCOCCAL INFECTIONS 
ADULTS, ADOLESCENTS AND CHILDREN >45 KG 
PHARYNGEAL, UROGENITAL, RECTAL 
 
 
 
 
• Ceftriaxone 250 mg IM once PLUS3 
• Azithromycin 1 g orally once  
 
 
Note: Use of an alternative regimen for pharyngeal 
gonorrhea should be followed by a test-of-cure 14 days 
after treatment.4  
For urogenital or rectal infections ONLY, and ONLY if 
ceftriaxone is not available: 
• Cefixime 400mg orally once 
PLUS3 
• Azithromycin 1 g orally once  
OR in case of azithromycin allergy 
• Doxycycline 100 mg orally 2 times a day for 7 days 
 
For azithromycin allergy: 
! Ceftriaxone 250 mg IM once PLUS3 
! Doxycycline 100 mg orally 2 times a day for 7 days 
 
For cephalosporin allergy or IgE-mediated penicillin 
allergy:  
! Gemifloxacin 320 mg orally once OR 
! Gentamicin 240 mg IM once 
PLUS3 
! Azithromycin 2 g orally once 
ADULTS AND ADOLESCENTS 
CONJUNCTIVAL 
• Ceftriaxone 1 g IM once PLUS3 
! Azithromycin 1 g orally once, plus consider lavage of 
infected eye with saline solution once 
No specific alternative regimens exist. CHILDREN !45 KG • Ceftriaxone 25-50 mg/kg IV or IM once (max 250 mg) 
NEONATES 
OPHTHALMIA NEONATORUM 
INFANTS BORN TO INFECTED MOTHERS 
• Ceftriaxone 25-50 mg/kg IV or IM once (max 250 mg) 
CHLAMYDIAL INFECTIONS 
ADULTS AND CHILDREN AGED >8 YEARS 
• Azithromycin 1 g orally once OR 
• Doxycycline5 100 mg orally 2 times a day 
for 7 days 
• Erythromycin base 500 mg orally 4 times a day for 7 days6 OR 
• Erythromycin ethylsuccinate 800 mg orally 4 times a day for 7 days6 
OR 
• Levofloxacin7 500 mg orally once a day for 7 days OR 
• Ofloxacin7 300 mg orally 2 times a day for 7 days 
CHILDREN "45 KG BUT AGED <8 YEARS • Azithromycin 1 g orally once No specific alternative regimens exist. 
CHILDREN <45 KG AND NEONATES • Erythromycin base or ethylsuccinate 50 
mg/kg/day orally divided into four doses 
daily for 14 days8 
For ophthalmia neonatorum: 
! Azithromycin 20 mg/kg/day orally once a day for 3 days9, 
PREGNANCY • Azithromycin 1 g orally once   
! Amoxicillin 500 mg orally 3 times a day for 7 days OR 
• Erythromycin base 500 mg orally 4 times a day for 7 days (or 250 mg 
orally 4 times a day for 14 days) OR 
• Erythromycin ethylsuccinate 800 mg orally 4 times a day for 7 days (or 
400 mg orally 4 times a day for 14 days) 
NONGONOCOCCAL URETHRITIS 
ADULT MALES 
• Azithromycin 1 g orally once10 OR 
• Doxycycline5 100 mg orally 2 times a day 
for 7 days 
• Erythromycin base 500 mg orally 4 times a day for 7 days6 OR  
• Erythromycin ethylsuccinate 800 mg orally 4 times a day for 7 days6 
OR 
• Levofloxacin7 500 mg orally once a day for 7 days OR 
• Ofloxacin7 300 mg orally 2 times a day for 7 days 
EPIDIDYMITIS11 
LIKELY DUE TO CHLAMYDIA AND GONORRHEA 
 
• Ceftriaxone 250 mg IM once PLUS 
• Doxycycline5 100 mg orally 2 times a day for 10 days No specific alternative regimens exist. 
LIKELY DUE TO CHLAMYDIA AND GONORRHEA AND 
ENTERIC ORGANISMS  
(MEN WHO PRACTICE INSERTIVE ANAL SEX) 
! Ceftriaxone 250 mg IM once PLUS 
! Levofloxacin7 500 mg orally once a day for 10 days OR 
! Ofloxacin7 300 mg orally twice a day for 10 days 
No specific alternative regimens exist. 
                                                            
1 Some specialists recommend benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completion of neurosyphilis (including ocular syphilis) treatment. 
2 Tetracycline/doxycycline contraindicated; erythromycin not recommended because it does not reliably cure an infected fetus; data insufficient to recommend azithromycin or ceftriaxone. 
3 Dual therapy for gonococcal infection recommended for all patients with gonorrhea regardless of chlamydia test results. 
4 Test of cure no longer necessary in cases of uncomplicated urogenital or rectal gonorrhea treated with recommended or alternative regimens. Test-of-cure for gonorrhea should be performed with culture or with 
nucleic acid amplification (NAAT) if culture not available. If NAAT positive, confirmatory culture recommended. If treatment failure suspected: culture, perform antimicrobial susceptibility testing, notify and consult with 
the state health department, and/or consult with an infectious disease specialist, an STD/HIV Prevention Training Center (www.nnptc.org), or CDC.   
5 Doxycycline not recommended during pregnancy, lactation, or for children <8 years of age. 
6 If patient cannot tolerate high dose erythromycin schedules, change to lower dose for longer (see under pregnancy alternatives). 
7 Quinolones not recommended for use in patients <18 years of age, and contraindicated in pregnant women. 
8 Efficacy of treating neonatal chlamydial conjunctivitis and pneumonia is about 80%. A second course of therapy may be required. An association between oral erythromycin and infantile hypertrophic pyloric stenosis 
(IHPS) has been reported in infants aged <6 weeks. See complete CDC guidelines for more information. 
9 Data on efficacy of azithromycin for ophthalmia neonatorum limited, so follow-up recommended to assess response. An association between oral azithromycin and infantile hypertrophic pyloric stenosis (IHPS) has 
been reported in infants aged < 6 weeks. See complete CDC guidelines for more information.  
10 Infections with M. genitalium may respond better to azithromycin, although azithromycin efficacy may be declining. 
11 Given increase in quinolone resistant gonorrhea, use of ofloxacin or levofloxacin alone recommended only if infection more likely caused only by enteric gram-negative organisms and gonorrhea has been ruled out. 
All Suspect Syphilis Cases:          
 
Call the STD Program at 
(617) 983-6940 for past titers and 
treatment. 
Partner Management: Expedited 
partner therapy (EPT) is allowed in 
Massachusetts for treatment of partners 
of patients infected with chlamydia. For 
more information, go to 
www.mass.gov/dph/cdc/std.  
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DISEASE RECOMMENDED TREATMENT ALTERNATIVES 
(use only if recommended regimens are contraindicated) 
PELVIC INFLAMMATORY DISEASE (outpatient management) 
ADULT FEMALES 
• Ceftriaxone 250 mg IM once OR 
• Cefoxitin 2 g IM once plus probenecid 1 g orally once OR 
• Other parenteral third generation cephalosporin (e.g., 
ceftizoxime or cefotaxime) 
PLUS 
• Doxycycline5 100 mg orally 2 times a day for 14 days 
WITH OR WITHOUT 
• Metronidazole12 500 mg orally twice a day for 14 days 
See complete CDC guidelines for alternatives. 
PREGNANCY Patients should be hospitalized and treated with recommended IV therapy (see complete CDC guidelines). 
CHANCROID 
ADULTS 
 
• Azithromycin13 1 g orally once OR 
• Ceftriaxone13 250 mg IM once OR 
• Ciprofloxacin7 500 mg orally 2 times a day for 3 days OR 
• Erythromycin base6 500 mg orally 3 times a day for 7 days  
No specific alternative regimens exist. 
BACTERIAL VAGINOSIS (BV) 
ADULT FEMALES 
• Metronidazole12 500 mg orally 2 times a day for 7 days OR 
• Metronidazole gel 0.75%, 5 g intravag. once a day for 5 days OR 
• Clindamycin cream 2%, 5 g intravag. at bedtime for 7 days14 
• Tinidazole15 2 g orally once daily for 2  days OR 
• Tinidazole15 1 g orally once daily for 5 days OR 
• Clindamycin 300 mg orally 2 times a day for 7 days OR 
• Clindamycin ovules 100 mg intravag. at bedtime for 3 days14 
PREGNANCY Treatment is recommended for all symptomatic pregnant women.16  
TRICHOMONIASIS 
ADULTS • Metronidazole
12 2 g orally once OR 
• Tinidazole15 2 g orally once 
• Metronidazole12,17 500 mg orally 2 times a day for 7 days 
PEDICULOSIS PUBIS18 
 • Permethrin 1% cream rinse applied to affected area and washed 
off after 10 minutes OR 
• Pyrethrins with piperonyl butoxide applied to affected area and 
washed off after 10 minutes 
• Malathion 0.5% lotion applied for 8-12 hours and washed off 
OR 
• Ivermectin19 250 mcg/kg orally once, repeated in 2 weeks 
SCABIES 
 • Permethrin20 5% cream applied to all areas of the body from the 
neck down and washed off after 8-14 hours OR 
• Ivermectin19 200 mcg/kg orally, repeated in 2 weeks 
• Lindane21 1% 1 oz of lotion or 30 g of cream applied thinly to 
all areas of the body from neck down and washed off after 8 
hours   
GENITAL HERPES SIMPLEX: See complete CDC guidelines for the management of herpes in pregnancy and in the neonate. 
ADULTS 
FIRST CLINICAL EPISODE22  
• Acyclovir 400 mg orally 3 times a day for 7-10 days OR 
• Acyclovir 200 mg orally 5 times a day for 7-10 days OR 
• Valacyclovir 1 g orally 2 times a day for 7-10 days OR 
• Famciclovir23 250 mg orally 3 times a day for 7-10 days  
 
ADULTS 
EPISODIC THERAPY FOR RECURRENCE 
• Acyclovir 400 mg orally 3 times a day for 5 days OR 
• Acyclovir 800 mg orally 2 times a day for 5 days OR 
• Acyclovir 800 mg orally 3 times a day for 2 days OR 
• Valacyclovir 500 mg orally 2 times a day for 3 days OR 
• Valacyclovir 1 g orally once a day for 5 days OR 
• Famciclovir23 125 mg orally 2 times a day for 5 days OR 
• Famciclovir23 1 g orally 2 times a day for 1 day OR 
• Famciclovir23 500 mg orally once, followed by 250 mg orally 2 
times a day for 2 days 
 
 ADULTS 
SUPPRESSIVE THERAPY FOR RECURRENCE 
• Acyclovir 400 mg orally 2 times a day OR 
• Valacyclovir 500 mg orally once a day OR 
• Valacyclovir 1 g orally once a day OR 
• Famciclovir23 250 mg orally 2 times a day 
 
HIV INFECTION Higher doses and/or longer therapy recommended. See complete CDC guidelines. 
GENITAL WARTS 
External or Perianal 
 
PROVIDER-ADMINISTERED 
• Cryotherapy with liquid nitrogen or cryoprobe. Repeat applications every 1-2 weeks if 
necessary OR 
• Surgical removal OR 
• Trichloroacetic acid (TCA) or bichloroacetic acid (BCA) 80% -90%. Apply small 
amount only to warts. Allow to dry. If excess amount applied, powder with talc, baking 
soda or liquid soap. Repeat weekly if necessary. 
 
PATIENT-APPLIED 
• Imiquimod 5% cream.24 Apply once daily at bedtime 3 times a week for up to 16 weeks. 
Wash treatment area with soap and water 6-10 hours after application OR 
! Imiquimod 3.75% cream.24  Apply once daily at bedtime every day for up to 16 weeks. 
Wash treatment area with soap and water 6-10 hours after application OR  
• Podofilox 0.5% solution or gel.25 Apply 2 times a day for 3 days, followed by 4 days of 
no therapy, 4 cycles max. Total wart area should not exceed 10 cm2 and total volume 
applied daily not to exceed 0.5 ml OR 
•        Sinecatechins 15% ointment.26 Applied 3 times a day for up to 16 weeks. Do not   
          wash off. 
Urethral Meatus 
 
• Cryotherapy with liquid nitrogen  
 
OR 
 
• Surgical removal 
Vaginal27, Cervical28 or Intra-Anal29 
 
• Cryotherapy with liquid nitrogen 
 
OR 
 
• Surgical removal 
 
OR 
 
• TCA or BCA 80%-90%. Apply 
small amount only to warts. Allow 
to dry. If excess amount applied, 
powder with talc, baking soda or 
liquid soap. Repeat weekly if 
necessary. 
 
                                                            
12 Consuming alcohol should be avoided during treatment with metronidazole and for 24 hours thereafter. Multiple studies and meta-analyses have not demonstrated an association between metronidazole use during 
pregnancy and teratogenic or mutagenic effects in newborns. In lactating women administered metronidazole, withholding breastfeeding during treatment and for 12–24 hours after last dose will reduce exposure of 
infant to metronidazole. 
13 Because data are limited concerning efficacy of azithromycin and ceftriaxone regimens in HIV-infected persons, these regimens should be used for such patients only if follow-up can be ensured. 
14 Clindamycin cream and ovules are oil-based and may weaken latex condoms and diaphragms for 3-5 days after use (refer to clindamycin product labeling for additional information). Although older studies indicated 
a possible link between use of vaginal clindamycin during pregnancy and adverse outcomes for the newborn, newer data demonstrate that this treatment approach is safe for pregnant women. 
15 Consuming alcohol should be avoided during treatment with tinidazole and for 72 hours thereafter. Tinidazole safety during pregnancy is not established. Interruption of breastfeeding is recommended during 
treatment and for 3 days after last dose. 
16 Because oral therapy has not been shown to be superior to topical therapy for treating symptomatic BV in effecting cure or preventing adverse outcomes in pregnancy, symptomatic pregnant women can be treated 
with either oral or vaginal regimens recommended for nonpregnant women, except as noted. Metronidazole 250 mg orally 3 times a day for 7 days is also a recommended regimen for pregnant women. 
17 Regimen of 7 days of metronidazole may be more effective than single dose metronidazole in women coinfected with trichomoniasis and HIV. 
18 Lindane no longer recommended because of toxicity. Pregnant or lactating women should be treated either with permethrin or pyrethrins with piperonyl butoxide. 
19 Ivermectin not recommended for pregnant or lactating women, or children who weigh <15 kg. 
20 Permethrin is the preferred treatment in infants and young children. 
21 Lindane no longer recommended as first line therapy because of toxicity. Lindane not to be used immediately after a bath, in persons with extensive dermatitis and women who are pregnant or lactating, or children 
aged <10 years. 
22 Treatment can be extended if healing is incomplete after 10 days of therapy. 
23 Famciclovir efficacy and safety not established in patients <18 years of age. 
24 May weaken condoms and vaginal diaphragms. Data from studies of humans are limited regarding use of imiquimod in pregnancy, but animal data suggest imiquimod poses low risk. 
25 Podofilox is contraindicated in pregnancy. 
26 Sinecatechins not recommended for HIV-infected persons, immunocompromised persons, or persons with clinical genital herpes. Safety of sinecatechins in pregnancy is unknown. 
27 Cryoprobe is not recommended secondary to risk for vaginal perforation and fistula formation. 
28 Exophytic cervical warts warrant biopsy to exclude high-grade squamous intraepithelial lesions before treatment is initiated. Management should include consultation with a specialist. 
29 Many persons with anal warts may also have them in the rectal mucosa. Inspect rectal mucosa by digital examination or anoscopy. Management should include consultation with a specialist. 
